Korean pharmaceutical firms urged to adopt U.S. and E.U. risk management practices

Local pharmaceutical companies need to implement safety and other best practices to comply with any possible litigation and regulatory risks in U.S. and European markets, according to a foreign executive for Chubb Group of Insurance Companies.

In a recent seminar, U.S. and Korean speakers issued this caution at a seminar organized by Chubb Group of Insurance Companies for the Korea Health In...